Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Behind the Deal: PGP Advises on Urology Transaction

Behind the Deal: PGP Advises on Urology Transaction

On September 4, Physician Growth Partners (PGP) announced that it worked as the financial advisor to Keystone Urology Specialists in its acquisition by Solaris Health. Based out of four Lancaster, Pennsylvania MSA locations, Keystone Urology Specialists is run by a team of 9 physicians. The practice has been in business for more than 55 years and has provided service to more than 25,000 unique patients each year.   Solaris Health, a portfolio company of private equity firm Lee Equity Partners, is a national healthcare platform committed to enhancing access to specialty healthcare. The group was formed in June 2020 when Lee Equity Partners purchased and merged Integrated Medical... Read More »
Green Clinic Forms Partnership With Allegiance Health

Green Clinic Forms Partnership With Allegiance Health

Green Clinic announced in September 2024 that it will be acquired by Allegiance Health Management’s CEO, Rock Bordelon, and form a partnership with the company. The partnership was announced in a Facebook post by Green Clinic on September 17, 2024. Financial terms of the deal were not disclosed. Green Clinic is a multi-specialty clinic, providing both primary and specialty care to patients of all ages, from newborns to seniors. The company has nine locations across Louisiana. Allegiance Health Management is an acute and post-acute health system based in Bossier City, Louisiana. It operates 15 hospitals in Louisiana, Texas and Mississippi, bringing extensive years of healthcare... Read More »
Telix Buys U.S. Radiopharmacy Network RLS for $230 Million

Telix Buys U.S. Radiopharmacy Network RLS for $230 Million

Telix Pharmaceuticals announced that it has agreed to buy RLS from its parent company, RLS Group. The acquisition of RLS will expand Telix’s North American manufacturing and distribution platform. Kirkland & Ellis acted as advisor to RLS in the transaction. RLS is America’s only Joint Commission-accredited radiopharmacy network, with 31 radiopharmacies covering more than 85% of the population. RLS’ revenue for FY 2023 was $158 million, according to the original deal press release from September 23, 2024. It is based in Miramar, Florida. Telix is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. Telix... Read More »
Private Equity Drives 35% of Healthcare M&A Activity During Q3 2024

Private Equity Drives 35% of Healthcare M&A Activity During Q3 2024

Private equity (PE) mergers and acquisitions (M&A) in the healthcare market remained robust during Q3 2024, accounting for a significant portion of overall deal activity. Out of 453 deals during Q3 2024 (as of September 23, 2024), 158 involved PE acquirers and/or their portfolio companies, accounting for 35% of the total deals. This is consistent with the same 2023 period (July 1, 2023 – September 23, 2023), when 162 of 483 deals (34%) involved PE acquirers. However, it shows a slight decline from the same 2022 period (July 1, 2022 – September 23, 2022), when 222 of 575 deals (about 39%) involved PE acquirers. This trend highlights the continued interest and investment from... Read More »
Align ENT + Allergy Acquires Mid-Michigan ENT 

Align ENT + Allergy Acquires Mid-Michigan ENT 

Align ENT + Allergy, a portfolio company of Zenyth Partners, announced that it acquired Mid-Michigan ENT.   Mid-Michigan ENT has one location in East Lansing, Michigan. According to its website, there are five physicians on staff.  Align ENT + Allergy is a management services organization (MSO) supporting a community of physician-led ear, nose & throat (ENT) and allergy practices. Align provides non-clinical support services to private practices through a true partnership model, whereby partners gain the advantages of a professionalized MSO while retaining local control so that they can focus on providing care within their communities.  Align will continue to grow... Read More »
Imagen Dental Partners Acquires the Practice of Dr. Mark Weems 

Imagen Dental Partners Acquires the Practice of Dr. Mark Weems 

Imagen Dental Partners, based in Scottsdale, Arizona, announced that it acquired the practice of Dr. Mark Weems, which is based in Ada, Oklahoma. According to the website, Dr. Weems is supported by a team of eight employees.  Imagen Dental Partners is a dental partnership organization founded in 2020 that joins with dental practices, invests in them and supports their growth. Imagen Dental Partners supports practices in California, Arizona, Texas, Minnesota, Florida, Georgia, South Carolina, Tennessee, Kentucky, Illinois, Indiana, Ohio, Michigan, Oregon and Wisconsin.  This transaction marks Imagen Dental Partners’ 14th acquisition of 2024, and its first in Oklahoma for the... Read More »
Guided Practice Solutions Acquires 100th Location 

Guided Practice Solutions Acquires 100th Location 

On September 18, Guided Practice Solutions (GPS Dental) announced that it acquired its 100th practice location with the purchase of Taylor Street Dental. According to data captured in the LevinPro HC database, this acquisition represents the 364th Physician Medical Group transaction of the year, and the 192nd in the dental specialty.   Taylor Street Dental is located in one office in Springfield, Massachusetts. According to its website, there are four physicians on staff.  GPS Dental is a dental service organization founded in 2015 by Dr. Hunter Smith and Dr. William Little. It received a strategic investment by Main Post Partners in 2021.  Dr. Hunter Smith, CEO and Co-Founder of... Read More »
Stryker Completes Sixth Deal of 2024

Stryker Completes Sixth Deal of 2024

Stryker has made its sixth deal announcement of the year with the completion of its acquisition of NICO Corporation in Indianapolis, Indiana. This acquisition further strengthens Stryker’s commitment to neurotechnology through tumor and stroke care. Financial terms of the deal were not disclosed. NICO Corporation is a privately held company that provides a systematic approach to minimally invasive surgery for tumors and intracerebral hemorrhage procedures. Stryker develops, manufactures and markets specialty surgical and medical products. These include orthopedic implants, powered surgical instruments, endoscopic systems and patient care and handling equipment. Stryker impacts more... Read More »
Cardinal Health to Acquire Integrated Oncology Network for More Than $1.1 Billion

Cardinal Health to Acquire Integrated Oncology Network for More Than $1.1 Billion

On September 20, Cardinal Health announced that it entered into a definitive agreement to acquire Nashville, Tennessee-based Integrated Oncology Network (ION) for more than $1.1 billion in cash. ION is a physician-led independent community oncology network that partners directly with physicians, hospitals and other healthcare providers to offer the latest services and technologies to patients. Founded in 2008, ION has grown to more than 50 centers nationwide, providing a complete and integrated continuum of care including diagnostic testing, radiation oncology, medical oncology, urology and other ancillary services. Cardinal Health is an American multinational healthcare services company,... Read More »
Flourish Research Receives Strategic Majority Investment from Genstar Capital

Flourish Research Receives Strategic Majority Investment from Genstar Capital

Flourish Research has announced a strategic majority investment from San Francisco, California-based Genstar Capital. Based in New York City, Flourish Research is a fully integrated clinical trial organization in North America. The company has sites throughout Alabama, California, Florida, Illinois, North Carolina, Pennsylvania and Texas. Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research. Flourish Research was formed in 2021 by New York-based private equity firm NMS Capital. Genstar Capital is a private equity investment firm that makes leveraged investments in middle-market companies. Genstar has approximately $49... Read More »